Get started
Author

Sait Kitaplı

Observed names: Kitapli, Sait, Kitaplı, Sait, S. Kitapli, S. Kitaplı, S., Kitapli, Sait Kitapli, Sait KİTAPLI
Institution: Muğla University
Observed institution: Muğla University
ORCID: 0000-0002-1143-1864
Observed ORCID: 0000-0002-1143-1864
OpenAlex ID: A5092661411
COVID-19 and Carcinogenesis: Exploring the Hidden Links
2024 · Özgür Tanrıverdi, Ali Alkan, et al. · Cureus · 5
PDF
Real‐world effectiveness and safety of sacituzumab govitecan in patients with metastatic or unresectable locally advanced triple‐negative breast cancer: A multicenter study by the Turkish Oncology Group
2025 · Salih Tunbekici, Gokhan Sahin, et al. · International Journal of Cancer · 3
Elevated serum magnesium levels prompt favourable outcomes in cancer patients treated with immune checkpoint blockers
2024 · Sait Kitapli, Ali Alkan, et al. · European Journal of Cancer · 3
Real‐world comparison of cabozantinib and sunitinib in advanced non‐clear cell renal cell carcinoma: A multicenter study by the Turkish Oncology Group
2025 · Gökhan Şahin, Esmanur Kaplan Tüzün, et al. · International Journal of Cancer · 2
Death anxiety—we have more to go
2024 · Ali Alkan, Sait Kitaplı, et al. · Supportive Care in Cancer · 2
Ten-year risk of second primary malignancies among chemotherapy-treated early-stage breast cancer survivors: a multicentre cohort study from the Turkish Oncology Group
2026 · Haydar Cagatay Yuksel, Elvina Almuradova, et al. · Frontiers in Oncology · 1
PDF
First-Line Treatment After Perioperative FLOT in Recurrent Gastric and Gastroesophageal Junction Cancer: A Turkish Oncology Group (TOG) Multicenter Real-World Analysis
2026 · Mustafa Seyyar, Pervin Can Şancı, et al. · Medicina · 1
Integration of Ki67 and Pan-Immune-Inflammation Value (PIV) into a predictive nomogram for pathologic complete response in triple-negative breast cancer
2026 · Taliha Guclu-Kantar, Ozgur Tanriverdi, et al. · BMC Cancer · 1
Author Correction: The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study
2025 · Neslihan Özyurt, Ali Alkan, et al. · Scientific Reports · 1
The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study
2024 · Neslihan Özyurt, Ali Alkan, et al. · Scientific Reports · 1
Immunotherapy in Gynecologic (Ovary, Endometrium and Servics) Cancer
2024 · Sait Kitapli, Ali Alkan · 1
Comparison of anthracycline-containing and anthracycline-free regimens in neoadjuvant HER-2 positive breast cancer treatment
2024 · Murat Bardakci, Hilal Karakas, et al. · Scientific Reports · 1
Management of Nasal Lobular Capillary Hemangioma with Sunitib
2023 · Ali ALKAN, Bilge Can UYAR, et al. · Journal of Oncological Sciences · 1
PDF
Breast Cancer Metastasis to Nasal Septum
2023 · Mehmet KAPAN, Erdoğan ÖZGÜR, et al. · Journal of Oncological Sciences · 1
PDF
Active Helicobacter pylori Infection and Survival Outcomes in De Novo Metastatic Colorectal Cancer: A Retrospective Cohort Study
2026 · Sait Kitapli, Ali Alkan, et al. · Helicobacter
PDF
Tyrosine Kinase Inhibitor Therapy in Metastatic Medullary Thyroid Carcinoma: Real-World Data from Turkish Oncology Group
2026 · Sedat Yıldız, Hacer Demir, et al. · Journal of Clinical Medicine
PDF
160eP Exploring the prognostic value of the magnesium–immune prognostic score (MIPS) in metastatic non-small cell lung cancer receiving nivolumab
2026 · S. Kitapli, A. Alkan, et al. · ESMO Open
PDF
Knowledge, perceptions and attitudes toward diabetes care in oncology: a pilot survey across specialties (DiaLog Study)
2026 · Guler Nur Tekustun, Besra Hazal Yesil-Gurel, et al. · Endocrine
Temporal Trends in Clinicopathological Features and Outcomes of De Novo Metastatic Luminal A Breast Cancer: A Retrospective Multicenter Analysis (2017–2025)
2026 · Bilgin Demir, Özgür Tanrıverdi, et al. · Cancer Investigation
Proliferation-Guided Risk Stratification in HER2-Low versus HER2-Positive Hormone Receptor-Positive Breast Cancer: A Multicenter Retrospective Analysis
2026 · Sait Kitapli, Özgür Tanrıverdi, et al. · Oncology Research and Treatment
Temporal Trends in Clinicopathological Features and Outcomes of De Novo Metastatic Luminal A Breast Cancer: A Retrospective Multicenter Analysis (2017–2025)
2026 · Demir, Bilgin, Tanrıverdi, Özgür, et al. · Figshare
Supplementary Material for: Proliferation-Guided Risk Stratification in HER2-Low vs. HER2-Positive Hormone Receptor-Positive Breast Cancer: A Multicenter Retrospective Analysis
2026 · karger, figshare admin, S., Kitapli, et al. · Figshare
Exploring the prognostic value of the magnesium–immune prognostic score (MIPS) in metastatic non-small cell lung cancer receiving Nivolumab
2025 · Sait Kitapli, Melih Akpunar, et al. · Clinical & Translational Oncology
Kanserde Takip
2025 · Şermin Dinç Sonuşen, İbrahim Bilen, et al. · Akademisyen Kitabevi eBooks
PDF
Baş ve Boyun, Mukozal, Diş ve Yumuşak Doku Sorunları
2025 · Sait Kitaplı · Akademisyen Kitabevi eBooks
Works count: 32
Citation count: 24
H-index: 3
I10-index:
Year
Topic
Type